Eculizumab in adolescents with PT-resistant aHUS
Research type
Research Study
Full title
An open-label, multi-centre controlled clinical trial of Eculizumab in adolescent patients with plasma therapy-resistant atypical Haemolytic-Uremic Syndrome (aHUS)
IRAS ID
17657
Contact name
Timothy H. J. Goodship
Contact email
Sponsor organisation
Alexion Pharmaceuticals, Inc
Eudract number
2008-006953-41
ISRCTN Number
N/A
Research summary
Research Summary not published at request of researcher
REC name
North East - Newcastle & North Tyneside 1 Research Ethics Committee
REC reference
09/H0906/42
Date of REC Opinion
28 May 2009
REC opinion
Further Information Favourable Opinion